BusinessKura Oncology Reports Third Quarter 2016 Financial ResultsBy Nasdaq OMXNov 7, 2016, 9:05 PM UTC
BusinessKura Oncology Presents Update on Pipeline Programs Targeting RAS-ERK Pathway at European Scientific Oncology ConferenceBy Nasdaq OMXNov 4, 2016, 11:30 AM UTC
BusinessKura Oncology to Participate in Two Upcoming Investor ConferencesBy Nasdaq OMXNov 1, 2016, 8:05 PM UTC
BusinessKura Oncology to Report Third Quarter 2016 Financial ResultsBy Nasdaq OMXOct 31, 2016, 8:05 PM UTC
BusinessKura Oncology to Participate in the 2016 Aegis Growth ConferenceBy Nasdaq OMXSep 14, 2016, 11:30 AM UTC
BusinessGeron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat in Myelodysplastic SyndromesBy Nasdaq OMXJan 14, 2016, 12:30 PM UTC